Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.

Rajavi Z, Safi S, Javadi MA, Azarmina M, Moradian S, Entezari M, Nourinia R, Ahmadieh H, Shirvani A, Shahraz S, Ramezani A, Dehghan MH, Shahsavari M, Soheilian M, Nikkhah H, Ziaei H, Behboudi H, Farrahi F, Falavarjani KG, Parvaresh MM, Fesharaki H, Abrishami M, Shoeibi N, Rahimi M, Javadzadeh A, Karkhaneh R, Riazi-Esfahani M, Manaviat MR, Maleki A, Kheiri B, Golbafian F.

J Ophthalmic Vis Res. 2016 Oct-Dec;11(4):394-414.

2.

Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration.

Szatmári-Tóth M, Kristóf E, Veréb Z, Akhtar S, Facskó A, Fésüs L, Kauppinen A, Kaarniranta K, Petrovski G.

Cell Death Dis. 2016 Sep 8;7(9):e2367. doi: 10.1038/cddis.2016.133.

3.

Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Gewaily D, Muthuswamy K, Greenberg PB.

Cochrane Database Syst Rev. 2015 Sep 9;(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. Review.

4.

Diabetic macular edema.

Stefánsson E.

Saudi J Ophthalmol. 2009 Jul;23(2):143-8. doi: 10.1016/j.sjopt.2009.06.002. Epub 2009 Aug 5.

5.

Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.

Karim R, Sykakis E, Lightman S, Fraser-Bell S.

Clin Ophthalmol. 2013;7:1109-44. doi: 10.2147/OPTH.S40268. Epub 2013 Jun 11.

6.

Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.

Demir M, Dirim B, Acar Z, Sendul Y, Oba E.

Indian J Ophthalmol. 2014 Mar;62(3):279-83. doi: 10.4103/0301-4738.105769.

7.

Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.

Zhou H, Yang L, Li H, Gong H, Cheng L, Zheng H, Zhang LM, Lan Y.

Int J Nanomedicine. 2012;7:4649-60. doi: 10.2147/IJN.S29690. Epub 2012 Aug 22.

8.

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

Kocabora MS, Yilmazli C, Taskapili M, Gulkilik G, Durmaz S.

Clin Ophthalmol. 2008 Mar;2(1):167-71.

9.

Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Gewaily D, Greenberg PB.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007324. doi: 10.1002/14651858.CD007324.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;9:CD007324.

10.

The problem of pressure elevation associated with intravitreal triamcinolone.

Conway MD.

Br J Ophthalmol. 2006 Aug;90(8):934-5. No abstract available.

11.

Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.

Chan CK, Mohamed S, Shanmugam MP, Tsang CW, Lai TY, Lam DS.

Br J Ophthalmol. 2006 Sep;90(9):1137-41. Epub 2006 May 17.

Supplemental Content

Support Center